Determination of acetazolamide compliance in patients with glaucoma
P. D. Alward and J. T. Wilensky
In an objective test to determine compliance with acetazolamide regimens by
patients with glaucoma, treated inpatients had lower carbon dioxide levels
(less than or equal to mEq/L) than untreated patients (greater than or
equal to 25 mEq/L). The test results may be inaccurate in some obese
diabetic patients with hyperglycemia and in some patients with obstructive
lung disease, such as asthma and emphysema. In an outpatient clinic
population, the test showed that 35% (30/87) of the patients did not seem
to be taking acetazolamide and 22% (19/87) seemed to be taking it less
frequently.
